ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645017 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645017; 2) Community: the network communities that were significantly associated with the response to NSC 645017; 3) Molecule: the relationships between components within communities and NSC 645017; 4) MDR: the compounds that were significantly associated with the NSC 645017.

NSC Compound Enrichment Correlation
NSC 659948 7-O-(2,3,6-Trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.0133299224082803 0.79006102
NSC 659950 7-O-(3,4-Di-O-acetyl-2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.0133299224082803 0.76958846
NSC 661820 Null 0.0133299224082803 0.25116581
NSC 664314 Null 0.0133299224082803 0.30060658
NSC 671009 2H-Thieno[3',4':4,5]cyclopent[1,2-d]oxazole- 2,7(7aH)-dione,4,6-dibromo-3,3a-dihydro- 0.0133299224082803 0.0053965958
NSC 675003 Benzofuran-3-carboxylic acid, 2,3-dihydro-7-hydroxy- 2-(3,4-dihydroxyphenyl)-5-(3-methoxy-3-oxo-1-propen-1-yl)-, methyl ester, stereoisomer 0.0133299224082803 0.30663777
NSC 675766 Null 0.0133299224082803 -0.029761399
NSC 681635 Camptothecin Derivative 0.0133299224082803 0.77182585
NSC 681639 Camptothecin Derivative 0.0133299224082803 0.7902421
NSC 685005 Null 0.0133299224082803 -0.085644678
Total:106  Current:38    [First] [Prev] [Next] [Last]